These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 8187381

  • 1. Vigabatrin in uncontrolled seizures: Belgian clinical experience. The Belgian Vigabatrin Evaluation Group.
    Lhoir A.
    Clin Neurol Neurosurg; 1994 Feb; 96(1):42-6. PubMed ID: 8187381
    [Abstract] [Full Text] [Related]

  • 2. Vigabatrin treatment in children.
    Fois A, Buoni S, Di Bartolo RM, Di Marco V, Mostardini R.
    Childs Nerv Syst; 1994 May; 10(4):244-8. PubMed ID: 7923235
    [Abstract] [Full Text] [Related]

  • 3. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
    Russ W.
    Schweiz Arch Neurol Psychiatr (1985); 1995 May; 146(2):55-9. PubMed ID: 7569836
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizures.
    Beran RG, Berkovic SF, Buchanan N, Danta G, Mackenzie R, Schapel G, Sheean G, Vajda F.
    Seizure; 1996 Dec; 5(4):259-65. PubMed ID: 8952010
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vigabatrin use in 72 patients with drug-resistant epilepsy.
    Buchanan N.
    Seizure; 1994 Sep; 3(3):191-6. PubMed ID: 8000713
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort.
    French JA, Mosier M, Walker S, Sommerville K, Sussman N.
    Neurology; 1996 Jan; 46(1):54-61. PubMed ID: 8559421
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Multicentre clinical evaluation of vigabatrin (Sabril) in mild to moderate partial epilepsies. French Neurologists Sabril Study Group.
    Arzimanoglou AA, Dumas C, Ghirardi L.
    Seizure; 1997 Jun; 6(3):225-31. PubMed ID: 9203252
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vigabatrin in the management of generalized seizures in children.
    Appleton RE.
    Seizure; 1995 Mar; 4(1):45-8. PubMed ID: 7788106
    [Abstract] [Full Text] [Related]

  • 19. [Vigabatrin--a new antiepileptic agent].
    Nakken KO, Henriksen O, Johannessen SI.
    Tidsskr Nor Laegeforen; 1994 Oct 10; 114(24):2843-4. PubMed ID: 7998031
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group.
    Chadwick D.
    Lancet; 1999 Jul 03; 354(9172):13-9. PubMed ID: 10406359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.